BRCA1 and nasopharyngeal carcinoma: By employing small, interfering RNA (si‐RNA) to knock down BRCA1 expression in the three NPC cell lines (Figure 6A–D), we observed alterations in cellular responsiveness to radiotherapy and cisplatin.